OUTSOURCING SUPPLY OPERATIONS
Quality and sustainability: the balancing act for pharma manufacturing
Trends in sustainability and quality assurance were key themes discussed at the CPHI Europe meeting, although the data reveals a lack of implementation of sustainable solutions.
IRENA MARAGKOU, HEALTHCARE RESEARCHER, CLINICAL TRIALS ARENA AND PHARMACEUTICAL TECHNOLOGY
Credit: Chokniti-Studio via
Shutterstock.com. T
rends in sustainability and quality assurance were key themes discussed amongst panelists at Convention on Pharmaceutical Ingredients (CPHI) Europe,
although the data reveals a lack of implementation of sustainable solutions. In recent years, sustainability has become a
trending term across various industries, including the biopharmaceutical sector. According to CPHI’s Annual Industry Report sustainability is a critical issue, with 90% of executives citing ‘visibility on supply chain partner’s sustainability record’ as ‘extremely important’ or ‘important’. Stakeholders across sectors gathered at the United Nations Climate Change Conference
10 | Clinical Trial Supply Handbook
(COP28) meeting to discuss initiatives to reduce carbon emissions and curb global warming to 1.5 degree Celsius below pre- industrial levels. At the pharmaceutical manufacturing-focused CPHI Europe conference, experts discussed how the biopharmaceutical sector in particular is taking a sometimes convoluted journey towards achieving sustainable practices. Chief among the listed challenges was
stringent regulations related to product safety and efficacy, as well as market pressures that have hindered the adoption of sustainable practices in the industry. Still, experts noted that the application of
sustainable practices and process efficiency are closely linked to each other, and that
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44
